4//SEC Filing
Cramer Pamela J. 4
Accession 0001104659-25-121181
CIK 0001649904other
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 4:30 PM ET
Size
9.0 KB
Accession
0001104659-25-121181
Insider Transaction Report
Form 4
Cramer Pamela J.
Chief Human Resources Officer
Transactions
- Exercise/Conversion
Common Stock
2025-12-11$27.35/sh+3,350$91,623→ 24,164 total - Exercise/Conversion
Stock Options (Right to Buy)
2025-12-11−3,350→ 8,375 totalExercise: $27.35Exp: 2033-01-31→ Common Stock (3,350 underlying) - Sale
Common Stock
2025-12-11$111.00/sh−3,350$371,850→ 20,814 total
Footnotes (2)
- [F1]The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2025.
- [F2]The stock options were granted on February 1, 2023. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date.
Documents
Issuer
RHYTHM PHARMACEUTICALS, INC.
CIK 0001649904
Entity typeother
Related Parties
1- filerCIK 0001873517
Filing Metadata
- Form type
- 4
- Filed
- Dec 14, 7:00 PM ET
- Accepted
- Dec 15, 4:30 PM ET
- Size
- 9.0 KB